Results 241 to 250 of about 1,166,800 (296)
Some of the next articles are maybe not open access.

Related searches:

HIV Protease Inhibitors

Current Pharmaceutical Design, 1996
H L Sham, D J Kempf
exaly   +6 more sources

Protease Inhibitors in the Clinic

Medicinal Chemistry, 2005
This review describes the clinical status (based on available information) of experimental drugs that inhibit enzymes called proteases, or more precisely a sub-class of proteases called peptidases that catalyse the hydrolysis of polypeptide main chain amide bonds.
Abbenante, Giovanni, Fairlie , David P.
openaire   +4 more sources

Proteases and protease inhibitors in cancer

Acta Histochemica, 1998
The second conference on 'Proteases and protease inhibitors in cancer' was organized by the American Association for Cancer Research (AACR) and Acta Pathologica Microbiologica et Immunologica Scandinavica (APMIS). To understand the role of proteinases and to develop relevant synthetic inhibitors to stop or slow the progression of cancer, an integrated ...
openaire   +4 more sources

Protease inhibitor monotherapy

Current Opinion in Infectious Diseases, 2011
The present review focuses on recent data about boosted protease inhibitor monotherapy for maintenance of HIV virological suppression.Until recently most of the trials of boosted protease inhibitor monotherapy have studied lopinavir/ritonavir monotherapy.
Ignacio, Pérez-Valero, Jose R, Arribas
openaire   +2 more sources

Molecular dynamics simulation of docking structures of SARS-CoV-2 main protease and HIV protease inhibitors

Journal of Molecular Structure, 2021
W B Cardoso, Mendanha Sebastiao A
exaly  

PROTEASE INHIBITORS

2000
CUMMINGS MAXWELL D   +5 more
  +16 more sources

A Review of the Current Landscape of SARS-CoV-2 Main Protease Inhibitors: Have We Hit the Bullseye Yet?

International Journal of Molecular Sciences, 2022
Santiago Garcia-Vallvé   +2 more
exaly  

Home - About - Disclaimer - Privacy